These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 27656483)
1. Study of Hepatic Osteodystrophy in Patients with Chronic Liver Disease. Karoli Y; Karoli R; Fatima J; Manhar M J Clin Diagn Res; 2016 Aug; 10(8):OC31-4. PubMed ID: 27656483 [TBL] [Abstract][Full Text] [Related]
2. Hepatic osteodystrophy. Goel V; Kar P Trop Gastroenterol; 2010; 31(2):82-6. PubMed ID: 20862980 [TBL] [Abstract][Full Text] [Related]
3. Hepatic osteodystrophy in cirrhosis due to alcohol-related liver disease. Pereira F; Azevedo R; Linhares M; Pinto J; Leitão C; Caldeira A; Tristan J; Pereira E; Sousa R; Banhudo A Rev Esp Enferm Dig; 2021 Aug; 113(8):563-569. PubMed ID: 33267594 [TBL] [Abstract][Full Text] [Related]
4. Investigation of the influential factors for hepatic osteodystrophy in chronic liver disease: A case-control survey among the patients attending a tertiary care hospital in a rural region of Northern India. Yadav E; Kaur RD; Sasan A; Garg S Tzu Chi Med J; 2023; 35(1):95-102. PubMed ID: 36866351 [TBL] [Abstract][Full Text] [Related]
5. High Prevalence of Hormonal Changes and Hepatic Osteodystrophy in Frail Patients with Cirrhosis-An Observational Study. Singh S; Taneja S; Tandon P; De A; Verma N; Premkumar M; Duseja A; Dhiman RK; Singh V J Clin Exp Hepatol; 2022; 12(3):800-807. PubMed ID: 35677501 [TBL] [Abstract][Full Text] [Related]
6. Osteodystrophy in patients with chronic hepatitis and liver cirrhosis. Tsuneoka K; Tameda Y; Takase K; Nakano T J Gastroenterol; 1996 Oct; 31(5):669-78. PubMed ID: 8887033 [TBL] [Abstract][Full Text] [Related]
7. Hepatic osteodystrophy and fracture risk prediction using FRAX tool in Indian patients with cirrhosis. De A; Ray D; Lamoria S; Sharma V; Khurana TR JGH Open; 2020 Oct; 4(5):945-949. PubMed ID: 33102768 [TBL] [Abstract][Full Text] [Related]
8. Prospective study of profile of hepatic osteodystrophy in patients with non-choleastatic liver cirrhosis and impact of bisphosphonate supplementation. Bansal RK; Kumar M; Sachdeva PR; Kumar A United European Gastroenterol J; 2016 Feb; 4(1):77-83. PubMed ID: 26966526 [TBL] [Abstract][Full Text] [Related]
9. Association between nutritional screening via the Controlling Nutritional Status index and bone mineral density in chronic liver disease of various etiologies. López-Larramona G; Lucendo AJ; Tenías JM Hepatol Res; 2015 Jun; 45(6):618-28. PubMed ID: 25059921 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of vitamin D status bone mineral density and dental health in children with cholestasis. Samra NM; Emad El Abrak S; El Dash HH; El Said El Raziky M; El Sheikh MA Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):368-377. PubMed ID: 29551613 [TBL] [Abstract][Full Text] [Related]
11. Bone health and vitamin D status in alcoholic liver disease. Kizilgul M; Ozcelik O; Delibasi T Indian J Gastroenterol; 2016 Jul; 35(4):253-9. PubMed ID: 27246833 [TBL] [Abstract][Full Text] [Related]
12. Hepatic Osteodystrophy: A Global (Re)View of the Problem. Barbu EC; Chițu-Tișu CE; Lazăr M; Olariu C; Bojincă M; Ionescu RA; Ion DA; Bădărău IA Acta Clin Croat; 2017 Sep; 56(3):512-525. PubMed ID: 29479918 [TBL] [Abstract][Full Text] [Related]
13. Males seropositive for hepatitis B surface antigen are at risk of lower bone mineral density: the 2008-2010 Korea National Health and Nutrition Examination Surveys. Baeg MK; Yoon SK; Ko SH; Han KD; Choi HJ; Bae SH; Choi JY; Choi MG Hepatol Int; 2016 May; 10(3):470-7. PubMed ID: 26850597 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of hepatic osteodystrophy and vitamin D deficiency in cirrhosis. Chinnaratha MA; Chaudhary S; Doogue M; McCormick RJ; Woodman RJ; Wigg AJ Intern Med J; 2015 Dec; 45(12):1230-5. PubMed ID: 26247615 [TBL] [Abstract][Full Text] [Related]
15. Hepatic osteodystrophy: An important matter for consideration in chronic liver disease. López-Larramona G; Lucendo AJ; González-Castillo S; Tenias JM World J Hepatol; 2011 Dec; 3(12):300-7. PubMed ID: 22216370 [TBL] [Abstract][Full Text] [Related]
16. Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients. Ersoy FF; Passadakis SP; Tam P; Memmos ED; Katopodis PK; Ozener C; Akçiçek F; Camsari T; Ateş K; Ataman R; Vlachojannis JG; Dombros AN; Utaş C; Akpolat T; Bozfakioğlu S; Wu G; Karayaylali I; Arinsoy T; Stathakis PC; Yavuz M; Tsakiris JD; Dimitriades CA; Yilmaz ME; Gültekin M; Karayalçin B; Yardimsever M; Oreopoulos DG J Bone Miner Metab; 2006; 24(1):79-86. PubMed ID: 16369903 [TBL] [Abstract][Full Text] [Related]
17. Bone density, vitamin D status, and disordered bone remodeling in end-stage chronic liver disease. Crosbie OM; Freaney R; McKenna MJ; Hegarty JE Calcif Tissue Int; 1999 Apr; 64(4):295-300. PubMed ID: 10089221 [TBL] [Abstract][Full Text] [Related]
18. Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease. Duarte MP; Farias ML; Coelho HS; Mendonça LM; Stabnov LM; do Carmo d Oliveira M; Lamy RA; Oliveira DS J Gastroenterol Hepatol; 2001 Sep; 16(9):1022-7. PubMed ID: 11595067 [TBL] [Abstract][Full Text] [Related]